These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19620325)

  • 1. Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant women.
    Karunajeewa HA; Salman S; Mueller I; Baiwog F; Gomorrai S; Law I; Page-Sharp M; Rogerson S; Siba P; Ilett KF; Davis TM
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4368-76. PubMed ID: 19620325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal Antimalarial Dose Regimens for Sulfadoxine-Pyrimethamine with or without Azithromycin in Pregnancy Based on Population Pharmacokinetic Modeling.
    Salman S; Baiwog F; Page-Sharp M; Griffin S; Karunajeewa HA; Mueller I; Rogerson SJ; Siba PM; Ilett KF; Davis TME
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.
    Benjamin JM; Moore BR; Salman S; Page-Sharp M; Tawat S; Yadi G; Lorry L; Siba PM; Batty KT; Robinson LJ; Mueller I; Davis TM
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4260-71. PubMed ID: 25963981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic properties of conventional and double-dose sulfadoxine-pyrimethamine given as intermittent preventive treatment in infancy.
    Salman S; Griffin S; Kose K; Pitus N; Winmai J; Moore B; Siba P; Ilett KF; Mueller I; Davis TM
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1693-700. PubMed ID: 21282434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic properties of azithromycin in pregnancy.
    Salman S; Rogerson SJ; Kose K; Griffin S; Gomorai S; Baiwog F; Winmai J; Kandai J; Karunajeewa HA; O'Halloran SJ; Siba P; Ilett KF; Mueller I; Davis TM
    Antimicrob Agents Chemother; 2010 Jan; 54(1):360-6. PubMed ID: 19858250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimester-Specific Population Pharmacokinetics and Other Correlates of Variability in Sulphadoxine-Pyrimethamine Disposition Among Ugandan Pregnant Women.
    Odongo CO; Bisaso KR; Ntale M; Odia G; Ojara FW; Byamugisha J; Mukonzo JK; Obua C
    Drugs R D; 2015 Dec; 15(4):351-62. PubMed ID: 26586482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya.
    Green MD; van Eijk AM; van Ter Kuile FO; Ayisi JG; Parise ME; Kager PA; Nahlen BL; Steketee R; Nettey H
    J Infect Dis; 2007 Nov; 196(9):1403-8. PubMed ID: 17922406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of chloroquine and monodesethylchloroquine in pregnancy.
    Karunajeewa HA; Salman S; Mueller I; Baiwog F; Gomorrai S; Law I; Page-Sharp M; Rogerson S; Siba P; Ilett KF; Davis TM
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1186-92. PubMed ID: 20086162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of Sulfadoxine and Pyrimethamine for Intermittent Preventive Treatment of Malaria During Pregnancy and After Delivery.
    de Kock M; Tarning J; Workman L; Nyunt MM; Adam I; Barnes KI; Denti P
    CPT Pharmacometrics Syst Pharmacol; 2017 Jul; 6(7):430-438. PubMed ID: 28597978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
    Peters PJ; Thigpen MC; Parise ME; Newman RD
    Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of sequential and simultaneous treatment with the combination chloroquine and sulfadoxine-pyrimethamine in acute uncomplicated Plasmodium falciparum malaria in the Philippines.
    Bustos DG; Lazaro JE; Gay F; Pottier A; Laracas CJ; Traore B; Diquet B
    Trop Med Int Health; 2002 Jul; 7(7):584-91. PubMed ID: 12100441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population Pharmacokinetics of Mefloquine Intermittent Preventive Treatment for Malaria in Pregnancy in Gabon.
    Ramharter M; Schwab M; Mombo-Ngoma G; Zoleko Manego R; Akerey-Diop D; Basra A; Mackanga JR; Würbel H; Wojtyniak JG; Gonzalez R; Hofmann U; Geditz M; Matsiegui PB; Kremsner PG; Menendez C; Kerb R; Lehr T
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
    Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scaling up of intermittent preventive treatment of malaria in pregnancy using sulphadoxine-pyrimethamine: prospects and challenges.
    Oyibo WA; Agomo CO
    Matern Child Health J; 2011 May; 15(4):542-52. PubMed ID: 20425139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of impact of artesunate on the disposition kinetics of sulfadoxine/pyrimethamine when the two drugs are concomitantly administered.
    Minzi OM; Gupta A; Haule AF; Kagashe GA; Massele AY; Gustafsson LL
    Eur J Clin Pharmacol; 2007 May; 63(5):457-62. PubMed ID: 17333157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic disposition of sulfadoxine in children with acute uncomplicated falciparum malaria treated with sulfadoxine-pyrimethamine in South West Nigeria.
    Gbotosho GO; Happi CT; Sijuade A; Sowunmi A; Oduola A
    Am J Ther; 2012 Sep; 19(5):338-45. PubMed ID: 19918170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy.
    Nyunt MM; Adam I; Kayentao K; van Dijk J; Thuma P; Mauff K; Little F; Cassam Y; Guirou E; Traore B; Doumbo O; Sullivan D; Smith P; Barnes KI
    Clin Pharmacol Ther; 2010 Feb; 87(2):226-34. PubMed ID: 19776738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania.
    Mikomangwa WP; Minzi O; Mutagonda R; Baraka V; Mlugu EM; Aklillu E; Kamuhabwa AAR
    Malar J; 2020 Apr; 19(1):160. PubMed ID: 32306955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial.
    Divala TH; Mungwira RG; Mawindo PM; Nyirenda OM; Kanjala M; Ndaferankhande M; Tsirizani LE; Masonga R; Muwalo F; Boudová S; Potter GE; Kennedy J; Goswami J; Wylie BJ; Muehlenbachs A; Ndovie L; Mvula P; Mbilizi Y; Tomoka T; Laufer MK
    Lancet Infect Dis; 2018 Oct; 18(10):1097-1107. PubMed ID: 30195996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent preventive therapy for malaria in pregnancy: is sulfadoxine-pyrimethamine the right drug?
    Parikh S; Rosenthal PJ
    Clin Pharmacol Ther; 2010 Feb; 87(2):160-2. PubMed ID: 20107451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.